Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. Secures Medical Device Production License

Stock News

Feb 05

Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. (300534.SZ) has announced that it has obtained a Medical Device Production License issued by the Gansu Provincial Medical Products Administration. The acquisition of this license signifies that the company's hemodialysis concentrate (powder) product is now qualified for both production and commercial sale. As a type of medical device used for hemodialysis, hemodialysis concentrate (powder) is widely applied in clinical settings for the treatment of acute renal failure and chronic renal failure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1110140111"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1110140111\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1110140111?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110140111","market":"hk","top_or_hot":-1,"title":"Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. Secures Medical Device Production License","media":"Stock News","content":"<p>Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. (300534.SZ) has announced that it has obtained a Medical Device Production License issued by the Gansu Provincial Medical Products Administration. The acquisition of this license signifies that the company's hemodialysis concentrate (powder) product is now qualified for both production and commercial sale. As a type of medical device used for hemodialysis, hemodialysis concentrate (powder) is widely applied in clinical settings for the treatment of acute renal failure and chronic renal failure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. Secures Medical Device Production License</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGansu Longshenrongfa Pharmaceutical Industry Co., Ltd. Secures Medical Device Production License\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-02-05 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. (300534.SZ) has announced that it has obtained a Medical Device Production License issued by the Gansu Provincial Medical Products Administration. The acquisition of this license signifies that the company's hemodialysis concentrate (powder) product is now qualified for both production and commercial sale. As a type of medical device used for hemodialysis, hemodialysis concentrate (powder) is widely applied in clinical settings for the treatment of acute renal failure and chronic renal failure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0056","symbol_name":"扶贫","start_time":0,"source_url":"","article_id":"1110140111","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110140111","pubTimestamp":1770281337,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. (300534.SZ) has announced that it has obtained a Medical Device Production License issued by the Gansu Provincial Medical Products...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","300534":"陇神戎发","BK0056":"扶贫","BK1583":"高瓴概念","BK0239":"医药制造","BK0132":"高送转概念","09996":"沛嘉医疗-B","BK1100":"医疗保健设备","09997":"康基医疗","BK1222":"医疗保健用品","BK1574":"生物医药B类股"},"translate_title":"甘肃陇神荣发医药工业有限公司取得医疗器械生产许可证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"300534":1,"09997":1,"09996":1},"content_text":"Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. (300534.SZ) has announced that it has obtained a Medical Device Production License issued by the Gansu Provincial Medical Products Administration. The acquisition of this license signifies that the company's hemodialysis concentrate (powder) product is now qualified for both production and commercial sale. As a type of medical device used for hemodialysis, hemodialysis concentrate (powder) is widely applied in clinical settings for the treatment of acute renal failure and chronic renal failure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}